Filing Details

Accession Number:
0001209191-11-059460
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-05 15:58:14
Reporting Period:
2011-12-01
Filing Date:
2011-12-05
Filing Date Changed:
2011-12-05
Accepted Time:
2011-12-05 15:58:14
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352455 Jane Wasman 15 Skyline Drive
Hawthorne NY 10532
Exec Vp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Disposition 2011-12-01 7,344 $22.92 57,570
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.73 to $23.18 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!